Development

A company launches to bring germline correction stateside

development2026-03-20

Claim

Cathy Tie launched Origin Genomics to advance precision germline gene correction and mitochondrial replacement therapy in the United States.

Reporting date: (not necessarily the event date)

Sources

Attribution and reporting linked by this record; links do not imply independent verification.

Knowledge graphopen in browser →

Reported in
Actor
Evidence for
Supersedes
Referenced by

Cite or correct this record

Suggest a correction — opens a GitHub draft for you to review and submit.